zetlon biotecH
Revolutionizing Fever Diagnosis: Unveiling the Hidden Cause
Our biotech company is dedicated to revolutionizing the diagnosis of fever epidemics by developing advanced diagnostic kits for precision testing
COMPANY PROFILe
zetlon Biotech Private Limited was formed in 2020 and recognised as a startup by the
Ministry of Commerce and Industry in 2021. Our mission is to address some of the most
pressing health challenges by leveraging cutting-edge technology and research.
zetlon Biotech’s commitment to excellence and innovation is reflected in our diverse
portfolio of products and services aimed at improving patient outcomes. Our team of
dedicated scientists, researchers, and industry experts work tirelessly to develop novel
diagnostic tools and therapeutic solutions. We believe in a future where healthcare is more
precise and accessible to all.
Vision
To serve the people with highly updated diagnostic technology,
ensuring important medical care to the patients
Mission
Through clinical diagnostics, our company will preserve the highest
standards of quality and ethical values in patient care.
UNVEILING MYSTERY FEVERS
Mystery fever epidemics occur in India every year during the monsoon season,
characterized by hallmark symptoms of infectious viral fevers. However, the
majority of these cases test negative for viral infections upon diagnosis. A
significant proportion (~80%) of these mystery fevers are identified as
lepidopterism, caused by the tiger moth *Asota caricae* , during fever epidemics.
Our group is developing diagnostic kits for the differential diagnosis of tiger moth
disease from viral infectious fevers, supported by BIRAC’s Biotechnology Ignition
Grant. This product would be the first detection kit for identifying *Asota* spp.
disease (IP filed), with no similar products available in India or elsewhere. The
diagnosis of tiger moth disease would enable
differential diagnosis, leading to timely and precise clinical treatment to the fever patients
clinical diagnostics
Choosing zetlon Biotech means partnering with acompany that is dedicated to excellence. Our
innovative solutions are backed by rigorous researchand a deep understanding of the challenges faced by the healthcare industry. We are committed to delivering products that not only meet but exceed the highest standards of quality and efficacy
What We Do
Our work focuses on creating innovative diagnostic
kits that revolutionize the way diseases are detected
and managed. With support from prestigious grants,
including BIRAC’s Biotechnology Ignition Grant, we
have pioneered the development of groundbreaking
technologies that fill critical gaps in current healthcare practices.
Our flagship products, designed for precision testing,
offer unprecedented accuracy and reliability, setting a
new standard in the industry.
OUR PRODUCTS
INDIRECT IgE ELISA FOR DETECTING TIGER MOTH DISEASE
Collaborative research environment
At zetlon Biotech, we foster a collaborative research environment
that brings together scientists, researchers, and industry experts from
diverse fields. This multidisciplinary approach enhances our ability
to innovate and accelerates the translation of research findings into
practical applications.
Publications
P.J. Wills, M. Anjana, M. Nitin, R. et. al. Population explosions of tiger moth lead to
lepidopterism mimicking infectious fever outbreaks. PLOS ONE 2016, 11 (4): e0152787.
doi.org/10.1371/journal.pone.0152787.
©2025. zetlon BIOTECH PRIVATE LIMITED. All Rights Reserved.